Missed opportunities for big savings from generic drugs in Europe

Missed opportunities for big savings from generic drugs in Europe ... Shifting patients from branded to less expensive generic medicines is an ...

Comparing Generic Drug Markets in Europe and the United States

Rising drug prices are putting pressure on health care budgets. Policymakers are assessing how they can save money through generic drugs.

As global markets for generic drugs fail, poor people pay the price

Healthy competition from generic drugs is often held up as a “cure” for high drug prices — a shared concern across rich and developing ...

Beneath the Surface: Unravelling the True Value of Generic Medicines

Medicines for Europe, Off patent industry new investments in EU manufacturing (2023). 13. European Pharmaceutical Review, Sandoz mobilises critical medicine ...

Europe: a missed opportunity, with dangers and hopes - The Lancet

By replicating essential medicines that are off patent, generics save both lives and money. Benefits include the expansion abroad of antiretroviral treatment by ...

MEDICINES FOR EUROPE ANATOMY OF A FAILURE TO LAUNCH

Generic and biosimilar medicines play a fundamental role in promoting pharmaceutical innovation and, by introducing competition, ensuring the ...

European Generic Medication Shortages Raise Concerns About US ...

A recent report forecasting that supplies of affordable generic medicine will decrease in the European drug market, in large part because of ...

Overcoming challenges in market access of generic medicines in ...

27, 28 More than half of the drug shortages in this study involved parenteral drugs, similar to data reported from the United States and several European ...

Medicine dealers: Europe's secret drug negotiations

Low-income European countries pay higher prices for cystic fibrosis drugs. Life-saving medicines, sold by Vertex Pharmaceuticals, are available ...

Overcoming challenges in market access of generic medicines in ...

Generic medicines can only enter the market when the patent on the originator medicine is expired and when a marketing authorisation and pricing and ...

The Role of Generic Medicines in Sustaining Healthcare Systems

Following several years of opportunity for savings in medicine spending fuelled by the expiration of ... Currently, 75% of the generic medicines consumed in ...

IQVIA Report Flags Challenges With Biosimilar Access, Savings ...

Access to novel biologic medicines presents an extra challenge for the biosimilar industry. Current pharmaceutical expenditure and policies, ...

Drug Repurposing of Generic Drugs: Challenges and the Potential ...

The European Medicine Agency (EMA) and the Safe and Timely Access to Medicines for Patients (STAMP) working group define drug repurposing as: “ ...

Estimating Savings Opportunities From Therapeutic Substitutions of ...

Most of the savings would be concentrated among substitutions for the same drug with a different dosage form ($2.9 million [43.8%]) and drugs in ...

How Big Pharma preys on poor countries – and patients pay the price

... prescription for the drug. ... The result is unequal access to medicines across Europe, with life-saving medicines out of reach in some countries.

The Impact of Reimbursement Practices on the Pharmaceutical ...

... European Medicines Agency 38 drugs (58 ... lost opportunity for savings from the Association of generic drug manufacturers in Slovakia.

A comparison of generic drug prices in seven European countries

... generic drugs in seven European countries. Results. There were large differences in generic drug prices between countries. However, the ...

Analysis of the Italian generic medicines retail market: - Lirias

The following search terms were used: Italy; drugs, generic; health policy; cost control; cost containment; drug costs; drug legislation: economics, ...

Inflation threatens supply of life-saving generics to Europe

In October, Medicines for Europe also called on politicians to address the effect of price rises and the costs of energy on medicine supply (B/ ...

Generic drug market growth: insights to 2030

Each year, drug makers lose exclusivity for popular medicines, forcing them to constantly research and launch new drugs to stay afloat. Some ...